Clinical Trial Detail

NCT ID NCT03434262
Title SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors St. Jude Children's Research Hospital
Indications

medulloblastoma

central nervous system cancer

brain cancer

brain ependymoma

Therapies

Ribociclib + Trametinib

Filgrastim + Gemcitabine + Ribociclib

Ribociclib + Sonidegib

Age Groups: child adult

Additional content available in CKB BOOST